Unicycive Therapeutics Statistics
Total Valuation
UNCY has a market cap or net worth of $165.81 million. The enterprise value is $126.68 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, before market open.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UNCY has 25.24 million shares outstanding. The number of shares has increased by 137.17% in one year.
| Current Share Class | 25.24M |
| Shares Outstanding | 25.24M |
| Shares Change (YoY) | +137.17% |
| Shares Change (QoQ) | +18.63% |
| Owned by Insiders (%) | 2.49% |
| Owned by Institutions (%) | 26.62% |
| Float | 22.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 271.31 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.87 |
| P/TBV Ratio | 5.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.59 |
| Quick Ratio | 2.18 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -415.73 |
Financial Efficiency
Return on equity (ROE) is -141.14% and return on invested capital (ROIC) is -96.02%.
| Return on Equity (ROE) | -141.14% |
| Return on Assets (ROA) | -45.66% |
| Return on Invested Capital (ROIC) | -96.02% |
| Return on Capital Employed (ROCE) | -97.75% |
| Weighted Average Cost of Capital (WACC) | 14.18% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.21M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.91% in the last 52 weeks. The beta is 1.80, so UNCY's price volatility has been higher than the market average.
| Beta (5Y) | 1.80 |
| 52-Week Price Change | +28.91% |
| 50-Day Moving Average | 6.64 |
| 200-Day Moving Average | 5.46 |
| Relative Strength Index (RSI) | 48.73 |
| Average Volume (20 Days) | 502,568 |
Short Selling Information
The latest short interest is 1.72 million, so 6.82% of the outstanding shares have been sold short.
| Short Interest | 1.72M |
| Short Previous Month | 1.96M |
| Short % of Shares Out | 6.82% |
| Short % of Float | 7.54% |
| Short Ratio (days to cover) | 3.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -29.52M |
| Pretax Income | -26.56M |
| Net Income | -26.56M |
| EBITDA | -29.48M |
| EBIT | -29.52M |
| Earnings Per Share (EPS) | -$1.67 |
Full Income StatementBalance Sheet
The company has $41.27 million in cash and $117,000 in debt, with a net cash position of $41.15 million or $1.63 per share.
| Cash & Cash Equivalents | 41.27M |
| Total Debt | 117,000 |
| Net Cash | 41.15M |
| Net Cash Per Share | $1.63 |
| Equity (Book Value) | 30.20M |
| Book Value Per Share | 1.37 |
| Working Capital | 30.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$31.32 million and capital expenditures -$24,000, giving a free cash flow of -$31.34 million.
| Operating Cash Flow | -31.32M |
| Capital Expenditures | -24,000 |
| Depreciation & Amortization | 34,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -31.34M |
| FCF Per Share | -$1.24 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
UNCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -137.17% |
| Shareholder Yield | -137.17% |
| Earnings Yield | -15.82% |
| FCF Yield | -18.67% |
Analyst Forecast
The average price target for UNCY is $38.00, which is 478.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.00 |
| Price Target Difference | 478.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 20, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
